-
MC2 Therapeutics Acquires Option to Phase 2 Oral Drug Candidate for Hidradenitis Suppurativa and Other Indications
B3C newswire
November 06, 2023
MC2 Therapeutics announced today that it has acquired option rights from Regranion, LLC to exclusively license Regranion’s RGRN-305 for the treatment of all human diseases, incl, oral treatment of HS globally, excluding the greater China region.
-
Eurofins Awarded U.S. Government Agreement To Expand National COVID-19 Testing
americanpharmaceuticalreview
June 02, 2021
Clinical Enterprise Inc., a Eurofins Scientific company, announced it has been awarded a U.S. Government agreement to expand national COVID-19 testing.
-
Clinical Ink Adds Executives
contractpharma
May 06, 2021
Clinical Ink, a global clinical trial technology company, has appointed CCO Chris Crucitti, COO Brian Donahue, and VP Project Operations Bill Barrasso. All three positions are newly created to help manage the company’s eCOA, ePRO+, DDC, and eConsent ...
-
Pfizer Unveils $500M Biotech Fund
contractpharma
June 03, 2020
New program to support continued biotechnology innovation across a portfolio of clinical-stage biotechnology companies.
-
DNA nanostructure stabilisation could enable translation into clinical use
europeanpharmaceuticalreview
March 09, 2020
Stabilising DNA nanostructures using glutaraldehyde to tether an electrostatic PEGylated oligolysine net to the DNA enabled them to survive degradation in animal models.
-
Verastem Oncology announces new strategic direction to advance its clinical development programmes
pharmaceutical-business-review
March 06, 2020
Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to developing and commercializing new medicines for patients battling cancer ...
-
Emergent Strengthens Clinical Ops
contractpharma
March 06, 2020
Emergent BioSolutions has partnered with Axiom Real-Time Metrics, a provider of unified eClinical solutions and services. Emergent has selected Axion’s Fusion eClinical suite as its global eClinical suite.
-
Robotic Surgery Saw 8.4-Fold Increase From 2012 to 2018
drugs
January 15, 2020
Hospitals that launch robotic surgery programs have a broad and immediate increase in the use of robotic surgery, accompanied by a decrease in traditional laparoscopic minimally invasive surgery, according to a study published online January in JAMA Netwo
-
Nonalcoholic Steatohepatitis Will Pose Clinical, Economic Burden
drugs
January 15, 2020
Nonalcoholic steatohepatitis (NASH) is expected to pose a significant clinical and economic burden during the next 20 years for U.S. patients with type 2 diabetes mellitus (T2DM), according to a study published online January in Diabetes Care.
-
Mentholated Popsicle Can Help Reduce Preoperative Thirst
drugs
January 03, 2020
Use of mentholated popsicles can reduce the intensity and discomfort from thirst during preoperative fasting, according to a study published online December in the Journal of Clinical Nursing.